Distinct intracellular trafficking of hepatitis C virus in myeloid and plasmacytoid dendritic cells

Journal of Virology

Volumn 84, Issue 17, 2010, Pages 8964-8969

  Lambotin, Mélanie ^a,b   Baumert, Thomas F ^a,b,c   Barth, Heidi ^a,b  

^a INSERM   (France)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c UNIVERSITY HOSPITAL OF STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CD81 ANTIGEN; CLAUDIN 1; HEPATITIS C ANTIGEN; SCAVENGER RECEPTOR BI;

ANTIGEN PRESENTATION; ARTICLE; BLOOD; BONE MARROW CELL; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL MIGRATION; CONTROLLED STUDY; ENDOCYTOSIS; HEPATITIS C VIRUS; HUMAN; HUMAN CELL; NONHUMAN; PLASMACYTOID DENDRITIC CELL; PRIORITY JOURNAL; VIRUS ENTRY; CELL CULTURE; DENDRITIC CELL; HEPATITIS C; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; PROTEIN TRANSPORT; VIROLOGY;

HEPATITIS C VIRUS;

CELLS, CULTURED; DENDRITIC CELLS; HEPACIVIRUS; HEPATITIS C; HEPATITIS C ANTIGENS; HUMANS; MYELOID CELLS; PROTEIN TRANSPORT;

EID: 77956641110     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00517-10     Document Type: Article

References (28)

1. Barth, H., T. J. Liang, and T. F. Baumert. 2006. Hepatitis C virus entry: molecular biology and clinical implications. Hepatology 44:527-535.
2. Barth, H., E. K. Schnober, C. Neumann-Haefelin, C. Thumann, M. B. Zeisel, H. M. Diepolder, Z. Hu, T. J. Liang, H. E. Blum, R. Thimme, M. Lambotin, and T. F. Baumert. 2008. Scavenger receptor class B is required for hepatitis C virus uptake and cross-presentation by human dendritic cells. J. Virol. 82:3466-3479.
3. Di Pucchio, T., B. Chatterjee, A. Smed-Sorensen, S. Clayton, A. Palazzo, M. Montes, Y. Xue, I. Mellman, J. Banchereau, and J. E. Connolly. 2008. Direct proteasome-independent cross-presentation of viral antigen by plasmacytoid dendritic cells on major histocompatibility complex class I. Nat. Immunol. 9:551-557.
4. Dubuisson, J., F. Helle, and L. Cocquerel. 2008. Early steps of the hepatitis C virus life cycle. Cell. Microbiol. 10:821-827.
5. + T-cell epitopes within hepatitis C virus NS3 and NS4 proteins. J. Virol. 79:12425-12433.
6. Gondois-Rey, F., C. Dental, P. Halfon, T. F. Baumert, D. Olive, and I. Hirsch. 2009. Hepatitis C virus is a weak inducer of interferon alpha in plasmacytoid dendritic cells in comparison with influenza and human herpesvirus type-1. PLoS One 4:e4319.
7. Grakoui, A., N. H. Shoukry, D. J. Woollard, J. H. Han, H. L. Hanson, J. Ghrayeb, K. K. Murthy, C. M. Rice, and C. M. Walker. 2003. HCV persistence and immune evasion in the absence of memory T cell help. Science 302:659-662.
8. Grouard, G., M. C. Rissoan, L. Filgueira, I. Durand, J. Banchereau, and Y. J. Liu. 1997. The enigmatic plasmacytoid T cells develop into dendritic cells with interleukin (IL)-3 and CD40-ligand. J. Exp. Med. 185:1101-1111.
9. Krieger, S. E., M. B. Zeisel, C. Davis, C. Thumann, H. J. Harris, E. K. Schnober, C. Mee, E. Soulier, C. Royer, M. Lambotin, F. Grunert, V. L. Dao Thi, M. Dreux, F. L. Cosset, J. A. McKeating, C. Schuster, and T. F. Baumert. 2010. Inhibition of hepatitis C virus infection by anti-claudin-1 antibodies is mediated by neutralization of E2-CD81-claudin-1 associations. Hepatology 51:1144-1157.
10. Lai, W. K., P. J. Sun, J. Zhang, A. Jennings, P. F. Lalor, S. Hubscher, J. A. McKeating, and D. H. Adams. 2006. Expression of DC-SIGN and DC-SIGNR on human sinusoidal endothelium: a role for capturing hepatitis C virus particles. Am. J. Pathol. 169:200-208.
11. Lambotin, M., S. Raghuraman, F. Stoll-Keller, T. F. Baumert, and H. Barth. 2010. A look behind closed doors: interaction of persistent viruses with dendritic cells. Nat. Rev. Microbiol. 8:350-360.
12. Liang, H., R. S. Russell, N. L. Yonkers, D. McDonald, B. Rodriguez, C. V. Harding, and D. D. Anthony. 2009. Differential effects of hepatitis C virus JFH1 on human myeloid and plasmacytoid dendritic cells. J. Virol. 83:5693-5707.
13. Marukian, S., C. T. Jones, L. Andrus, M. J. Evans, K. D. Ritola, E. D. Charles, C. M. Rice, and L. B. Dustin. 2008. Cell culture-produced hepatitis C virus does not infect peripheral blood mononuclear cells. Hepatology 48:1843-1850.
14. Mercer, J., and A. Helenius. 2009. Virus entry by macropinocytosis. Nat. Cell Biol. 11:510-520.
15. Meyer-Wentrup, F., D. Benitez-Ribas, P. J. Tacken, C. J. Punt, C. G. Figdor, I. J. de Vries, and G. J. Adema. 2008. Targeting DCIR on human plasmacytoid dendritic cells results in antigen presentation and inhibits IFN-alpha production. Blood 111:4245-4253.
16. Pietschmann, T., M. Zayas, P. Meuleman, G. Long, N. Appel, G. Koutsoudakis, S. Kallis, G. Leroux-Roels, V. Lohmann, and R. Bartenschlager. 2009. Production of infectious genotype 1b virus particles in cell culture and impairment by replication enhancing mutations. PLoS Pathog. 5:e1000475.
17. Rehermann, B. 2009. Hepatitis C virus versus innate and adaptive immune responses: a tale of coevolution and coexistence. J. Clin. Invest. 119:1745-1754.
18. Shiina, M., and B. Rehermann. 2008. Cell culture-produced hepatitis C virus impairs plasmacytoid dendritic cell function. Hepatology 47:385-395.
19. Steinman, R. M., and H. Hemmi. 2006. Dendritic cells: translating innate to adaptive immunity. Curr. Top. Microbiol. Immunol. 311:17-58.
20. Steinmann, D., H. Barth, B. Gissler, P. Schurmann, M. I. Adah, J. T. Gerlach, G. R. Pape, E. Depla, D. Jacobs, G. Maertens, A. H. Patel, G. Inchauspe, T. J. Liang, H. E. Blum, and T. F. Baumert. 2004. Inhibition of hepatitis C virus-like particle binding to target cells by antiviral antibodies in acute and chronic hepatitis C. J. Virol. 78:9030-9040.
21. Sun, P., S. Fernandez, M. A. Marovich, D. R. Palmer, C. M. Celluzzi, K. Boonnak, Z. Liang, H. Subramanian, K. R. Porter, W. Sun, and T. H. Burgess. 2009. Functional characterization of ex vivo blood myeloid and plasmacytoid dendritic cells after infection with dengue virus. Virology 383: 207-215.
22. Tarr, A. W., A. M. Owsianka, J. M. Timms, C. P. McClure, R. J. Brown, T. P. Hickling, T. Pietschmann, R. Bartenschlager, A. H. Patel, and J. K. Ball. 2006. Characterization of the hepatitis C virus E2 epitope defined by the broadly neutralizing monoclonal antibody AP33. Hepatology 43:592-601.
23. Thimme, R., D. Oldach, K. M. Chang, C. Steiger, S. C. Ray, and F. V. Chisari. 2001. Determinants of viral clearance and persistence during acute hepatitis C virus infection. J. Exp. Med. 194:1395-1406.
24. Wakita, T., T. Pietschmann, T. Kato, T. Date, M. Miyamoto, Z. Zhao, K. Murthy, A. Habermann, H. G. Krausslich, M. Mizokami, R. Bartenschlager, and T. J. Liang. 2005. Production of infectious hepatitis C virus in tissue culture from a cloned viral genome. Nat. Med. 11:791-796.
25. Watts, C. 2004. The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules. Nat. Immunol. 5:685-692.
26. Webster, D. P., P. Klenerman, J. Collier, and K. J. Jeffery. 2009. Development of novel treatments for hepatitis C. Lancet Infect. Dis. 9:108-117.
27. Wu, L., and Y. J. Liu. 2007. Development of dendritic-cell lineages. Immunity 26:741-750.
28. Zeisel, M. B., G. Koutsoudakis, E. K. Schnober, A. Haberstroh, H. E. Blum, F. L. Cosset, T. Wakita, D. Jaeck, M. Doffoel, C. Royer, E. Soulier, E. Schvoerer, C. Schuster, F. Stoll-Keller, R. Bartenschlager, T. Pietschmann, H. Barth, and T. F. Baumert. 2007. Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81. Hepatology 46:1722-1731.